Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New data highlight how Heartflow's AI software drives major shifts in heart care
One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.
First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve
A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.
AHA data challenge explores links between inflammation and heart disease
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others.
FDA recalls real-time glucose monitors after 56 injuries
Receivers on active glucose monitors manufactured by Dexcom are reportedly failing to send alerts when a patient’s blood sugar levels are dangerously high or low. There have been no deaths linked to the malfunction.
What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis
President Donald Trump has been diagnosed with chronic venous insufficiency. He underwent a complete evaluation due to swelling in his legs, the White House announced, and is in “excellent health” otherwise.

CMS eases regulations for COVID-19 response

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

Hypertension and COVID-19: 4 key things patients should know

What, exactly, do patients need to know about the relationship between hypertension and COVID-19?

TAVR outcomes worse than expected at 11% of US facilities

Transcatheter aortic valve replacement (TAVR) outcomes have been worse than expected for 11% of healthcare providers in the United States, according to a new analysis of data from 2015 to 2017.

HHS accelerates clinical trials for COVID-19 vaccines

HHS is speeding up the development and manufacturing of COVID-19 vaccines by partnering with Johnson & Johnson-owned Janssen Research and Development and Moderna Therapeutics.

EuroHeartCare 2020 canceled over COVID-19 concerns

The event was scheduled to occur June 4-6 in Seville, Spain. It has been rescheduled for June 17-19, 2021.

For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes

Oral anticoagulation medication can help minimize bleeding complications among AFib patients undergoing transcatheter aortic valve replacement (TAVR), according to new research out of Europe.

Humana, Cigna waive out-of-pocket costs for members treated for COVID-19

Humana and Cigna both announced March 30 that consumers would not have to pay for treatment related to COVID-19-covered services.

TAVR ‘viable and safe’ for patients with a bicuspid valve

Transcatheter aortic valve replacement (TAVR) procedures with a self-expanding artificial valve are “very viable and safe” for low-risk patients with a bicuspid aortic valve, according to new research that tracked the outcomes of 150 patients.

Clinical

New data highlight how Heartflow's AI software drives major shifts in heart care

First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve

AHA data challenge explores links between inflammation and heart disease

FDA recalls real-time glucose monitors after 56 injuries

What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis